CCDC58 is a potential biomarker for diagnosis, prognosis, immunity, and genomic heterogeneity in pan-cancer

Abstract Coiled-coil domain-containing 58 (CCDC58) is a member of the CCDC protein family. Similar to other members, CCDC58 exhibits potential tumorigenic roles in a variety of malignancies. However, there is no systematic and comprehensive pan-cancer analysis to investigate the diagnosis, prognosis...

Full description

Bibliographic Details
Main Authors: Kai Yang, Yan Ma, Weigang Chen, Lu Liu, Zelong Yang, Chaokui He, Nanbei Zheng, Xinyu Liu, Xin Cheng, Junbo Song, Yong Chen, Hongyu Qiao, Ruohan Zhang
Format: Article
Language:English
Published: Nature Portfolio 2024-04-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-59154-9
_version_ 1797209440734150656
author Kai Yang
Yan Ma
Weigang Chen
Lu Liu
Zelong Yang
Chaokui He
Nanbei Zheng
Xinyu Liu
Xin Cheng
Junbo Song
Yong Chen
Hongyu Qiao
Ruohan Zhang
author_facet Kai Yang
Yan Ma
Weigang Chen
Lu Liu
Zelong Yang
Chaokui He
Nanbei Zheng
Xinyu Liu
Xin Cheng
Junbo Song
Yong Chen
Hongyu Qiao
Ruohan Zhang
author_sort Kai Yang
collection DOAJ
description Abstract Coiled-coil domain-containing 58 (CCDC58) is a member of the CCDC protein family. Similar to other members, CCDC58 exhibits potential tumorigenic roles in a variety of malignancies. However, there is no systematic and comprehensive pan-cancer analysis to investigate the diagnosis, prognosis, immune infiltration, and other related functions of CCDC58. We used several online websites and databases, such as TCGA, GTEx, UALCAN, HPA, CancerSEA, BioGRID, GEPIA 2.0, TIMER 2.0, and TISIDB, to extract CCDC58 expression data and clinical data of patients in pan-cancer. Then, the relationship between CCDC58 expression and diagnosis, prognosis, genetic alterations, DNA methylation, genomic heterogeneity, and immune infiltration level were determined. In addition, the biological function of CCDC58 in liver hepatocellular carcinoma (LIHC) was investigated. Pan-cancer analysis results showed that CCDC58 was differentially expressed in most tumors and showed excellent performance in diagnosis and prediction of prognosis. The expression of CCDC58 was highly correlated with genetic alterations, DNA methylation, and genomic heterogeneity in some tumors. In addition, the correlation analysis of CCDC58 with the level of immune infiltration and immune checkpoint marker genes indicated that CCDC58 might affect the composition of the tumor immune microenvironment. Enrichment analysis showed that CCDC58-related genes were mainly linked to mitosis, chromosome, and cell cycle. Finally, biological function experiments demonstrated that CCDC58 plays an important role in tumor cell proliferation and migration. CCDC58 was first identified as a pan-cancer biomarker. It may be used as a potential therapeutic target to improve the prognosis of patients in the future.
first_indexed 2024-04-24T09:54:44Z
format Article
id doaj.art-d2442bc725de4ca599a953e48850d345
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-24T09:54:44Z
publishDate 2024-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-d2442bc725de4ca599a953e48850d3452024-04-14T11:14:23ZengNature PortfolioScientific Reports2045-23222024-04-0114111910.1038/s41598-024-59154-9CCDC58 is a potential biomarker for diagnosis, prognosis, immunity, and genomic heterogeneity in pan-cancerKai Yang0Yan Ma1Weigang Chen2Lu Liu3Zelong Yang4Chaokui He5Nanbei Zheng6Xinyu Liu7Xin Cheng8Junbo Song9Yong Chen10Hongyu Qiao11Ruohan Zhang12Department of Hepatobiliary Surgery, Xi Jing Hospital, Air Force Medical UniversityDepartment of Gynecology and Obstetrics, Xi Jing Hospital, Air Force Medical UniversityDepartment of Hepatobiliary Surgery, Xi Jing Hospital, Air Force Medical UniversityCollege of Life Sciences, Northwest UniversityDepartment of Hepatobiliary Surgery, Xi Jing Hospital, Air Force Medical UniversityDepartment of Oncology, The First Affiliated Hospital of Shanxi Medical UniversityDepartment of General Surgery, The First Affiliated Hospital of Jiamusi UniversityDepartment of Hepatobiliary Surgery, Xi Jing Hospital, Air Force Medical UniversityDepartment of Hepatobiliary Surgery, Xi Jing Hospital, Air Force Medical UniversityDepartment of Hepatobiliary Surgery, Xi Jing Hospital, Air Force Medical UniversityDepartment of Hepatobiliary Surgery, Xi Jing Hospital, Air Force Medical UniversityDepartment of Pediatrics, Xi Jing Hospital, Air Force Medical UniversityDepartment of Hepatobiliary Surgery, Xi Jing Hospital, Air Force Medical UniversityAbstract Coiled-coil domain-containing 58 (CCDC58) is a member of the CCDC protein family. Similar to other members, CCDC58 exhibits potential tumorigenic roles in a variety of malignancies. However, there is no systematic and comprehensive pan-cancer analysis to investigate the diagnosis, prognosis, immune infiltration, and other related functions of CCDC58. We used several online websites and databases, such as TCGA, GTEx, UALCAN, HPA, CancerSEA, BioGRID, GEPIA 2.0, TIMER 2.0, and TISIDB, to extract CCDC58 expression data and clinical data of patients in pan-cancer. Then, the relationship between CCDC58 expression and diagnosis, prognosis, genetic alterations, DNA methylation, genomic heterogeneity, and immune infiltration level were determined. In addition, the biological function of CCDC58 in liver hepatocellular carcinoma (LIHC) was investigated. Pan-cancer analysis results showed that CCDC58 was differentially expressed in most tumors and showed excellent performance in diagnosis and prediction of prognosis. The expression of CCDC58 was highly correlated with genetic alterations, DNA methylation, and genomic heterogeneity in some tumors. In addition, the correlation analysis of CCDC58 with the level of immune infiltration and immune checkpoint marker genes indicated that CCDC58 might affect the composition of the tumor immune microenvironment. Enrichment analysis showed that CCDC58-related genes were mainly linked to mitosis, chromosome, and cell cycle. Finally, biological function experiments demonstrated that CCDC58 plays an important role in tumor cell proliferation and migration. CCDC58 was first identified as a pan-cancer biomarker. It may be used as a potential therapeutic target to improve the prognosis of patients in the future.https://doi.org/10.1038/s41598-024-59154-9CCDC58Pan-cancerBiomarkerImmune infiltrationLIHC
spellingShingle Kai Yang
Yan Ma
Weigang Chen
Lu Liu
Zelong Yang
Chaokui He
Nanbei Zheng
Xinyu Liu
Xin Cheng
Junbo Song
Yong Chen
Hongyu Qiao
Ruohan Zhang
CCDC58 is a potential biomarker for diagnosis, prognosis, immunity, and genomic heterogeneity in pan-cancer
Scientific Reports
CCDC58
Pan-cancer
Biomarker
Immune infiltration
LIHC
title CCDC58 is a potential biomarker for diagnosis, prognosis, immunity, and genomic heterogeneity in pan-cancer
title_full CCDC58 is a potential biomarker for diagnosis, prognosis, immunity, and genomic heterogeneity in pan-cancer
title_fullStr CCDC58 is a potential biomarker for diagnosis, prognosis, immunity, and genomic heterogeneity in pan-cancer
title_full_unstemmed CCDC58 is a potential biomarker for diagnosis, prognosis, immunity, and genomic heterogeneity in pan-cancer
title_short CCDC58 is a potential biomarker for diagnosis, prognosis, immunity, and genomic heterogeneity in pan-cancer
title_sort ccdc58 is a potential biomarker for diagnosis prognosis immunity and genomic heterogeneity in pan cancer
topic CCDC58
Pan-cancer
Biomarker
Immune infiltration
LIHC
url https://doi.org/10.1038/s41598-024-59154-9
work_keys_str_mv AT kaiyang ccdc58isapotentialbiomarkerfordiagnosisprognosisimmunityandgenomicheterogeneityinpancancer
AT yanma ccdc58isapotentialbiomarkerfordiagnosisprognosisimmunityandgenomicheterogeneityinpancancer
AT weigangchen ccdc58isapotentialbiomarkerfordiagnosisprognosisimmunityandgenomicheterogeneityinpancancer
AT luliu ccdc58isapotentialbiomarkerfordiagnosisprognosisimmunityandgenomicheterogeneityinpancancer
AT zelongyang ccdc58isapotentialbiomarkerfordiagnosisprognosisimmunityandgenomicheterogeneityinpancancer
AT chaokuihe ccdc58isapotentialbiomarkerfordiagnosisprognosisimmunityandgenomicheterogeneityinpancancer
AT nanbeizheng ccdc58isapotentialbiomarkerfordiagnosisprognosisimmunityandgenomicheterogeneityinpancancer
AT xinyuliu ccdc58isapotentialbiomarkerfordiagnosisprognosisimmunityandgenomicheterogeneityinpancancer
AT xincheng ccdc58isapotentialbiomarkerfordiagnosisprognosisimmunityandgenomicheterogeneityinpancancer
AT junbosong ccdc58isapotentialbiomarkerfordiagnosisprognosisimmunityandgenomicheterogeneityinpancancer
AT yongchen ccdc58isapotentialbiomarkerfordiagnosisprognosisimmunityandgenomicheterogeneityinpancancer
AT hongyuqiao ccdc58isapotentialbiomarkerfordiagnosisprognosisimmunityandgenomicheterogeneityinpancancer
AT ruohanzhang ccdc58isapotentialbiomarkerfordiagnosisprognosisimmunityandgenomicheterogeneityinpancancer